Pulsed Electric Field Ablation for Atrial Flutter
Cavo-Tricuspid Isthmus Block Durability After Pulsed Electric Field Ablation
Recruiting
N/A
Interventional Study
Flutter, Atrial
Cavotricuspid Isthmus Dependent Right Atrial Flutter
Catheter Ablation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 150 (estimated)
- Sponsor
- Institute for Clinical and Experimental Medicine · Government
Who this trial is looking for
This trial is looking for adults with atrial flutter who are having catheter ablation. Participants will help researchers understand the effectiveness of a specific treatment and how long to wait after treatment before checking heart function.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old.
- I have been diagnosed with atrial flutter.
- I am undergoing catheter ablation for my condition.
- I am willing to sign informed consent.
You may not be able to join if
- I have a left atrium diameter greater than 65 mm.
- I have had a CTI ablation in the past.
- I have had heart valve surgery.
- I have significant heart valve problems.
- I am pregnant or breastfeeding.
- I have a life expectancy of less than one year.
- I have uncorrected congenital heart disease.
- I have active myocarditis.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study seeks to assess the acute durability of the CTI block when PEF energy is used. Second goal is to establish the optimal waiting time for the conduction recovery after PEF CTI ablation and to assess the utility of routine adenosine testing for dormant conduction. Moreover, this study aims to investigate the differences in acute efficacy and adverse events (hemolysis, coronary vasospasm) b…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients with paroxysmal AF undergoing PVI by PEF energy with documented typical atrial flutter or patients with persistent AF in whom catheter ablation of CTI is planned as a part of a complex procedure
* Age ≥ 18 years at the time of study enrollment
* Signed informed consen…
Contacts
No contact information available.